Medical Review Policy

Any content that makes claims about efficacy, safety, dosing, contraindications, drug interactions, or clinical outcomes requires medical review before publication. This includes:

• Compound profiles for FDA-approved medications (e.g., semaglutide, tirzepatide).
• Comparison pages between approved medications.
• Pages describing side effects, warnings, or contraindications.
• Guides about how medications work or how to discuss them with a clinician.
• Any page referencing specific clinical trial results or regulatory actions.

Pages covering purely definitional or structural topics (e.g., "What is a peptide?") may be reviewed by a qualified science editor rather than a licensed clinician.

Medical reviewers must hold an active, verifiable license in a relevant healthcare field (e.g., MD, DO, PharmD, NP, PA) in the jurisdiction where they practice. Reviewers must have relevant clinical or research experience related to the topic under review. We verify credentials through state licensing boards and professional directories.

Medical review means a qualified professional has read the content for clinical accuracy, appropriate caution, correct regulatory characterization, and responsible framing of evidence. The reviewer checks that claims are supported by cited sources, that uncertainty is communicated honestly, and that the content does not overstate benefits or minimize risks.

Medical review does not constitute an endorsement of any compound, a treatment recommendation, or a guarantee of safety or efficacy. It does not replace the judgment of a treating clinician who knows the individual patient. A reviewer's name on a page means the content was checked for accuracy — not that the reviewer prescribes or recommends the compound.

Each medically reviewed page displays:

• Date published — when the content was first published.
• Last medically reviewed — the date a qualified reviewer last verified the content.
• Last updated — the date of the most recent editorial change (which may be a non-clinical edit).

These dates are visible on the page and in structured data. We do not refresh review dates without a substantive review of the content.

When the FDA or other authoritative body issues a significant safety communication (e.g., a boxed warning, market withdrawal, or shortage-list change) affecting a compound we cover, we prioritize updating the relevant page within 72 hours. Urgent updates are made by our editorial team and flagged for the next available medical review.

We only publish reviewer pages for real, identified individuals who have agreed to be named and whose qualifications can be independently verified. Reviewer pages include the reviewer's name, credentials, license type and jurisdiction, specialty, relevant experience, conflict-of-interest disclosure, and a list of pages reviewed. We do not fabricate reviewer credentials or use pseudonymous experts.